Professor Garry Duffy is Personal Professor in Anatomy & Regenerative Therapies, within the School of Medicine at the National University of Ireland Galway. He leads the Duffy Lab at NUI Galway, which is focused on developing advanced biomaterials and devices to facilitate targeted delivery and future clinical translation of cell and drug based therapeutics to treat chronic diseases.
Central to this are the two European Consortia that Garry Coordinates, DRIVE and DELIVER, which gather a combined 14 industry, academic and clinical partners to design smart living biomaterial implants to treat Type 1 Diabetes.
Professor Duffy has a keen interest in developing minimally invasive surgical devices to enable the future translation of biomaterial based cell and drug therapy products. In 2016, he completed a Science Foundation Ireland-funded Academia to Industry Fellowship with Boston Scientific Corporate Research where he developed medical devices for the delivery of biomaterial based therapeutics.
He graduated with a PhD in the area of adult stem cell therapeutics for cardiovascular disease in 2008 under the supervision of Professor Frank Barry in the Regenerative Medicine Institute (REMEDI), NUI Galway. Professor Duffy is a two-time Fulbright Scholar. During his first Scholarship in June 2006, he carried out research in cardiovascular tissue engineering and stem cell biology at the Georgia Institute of Technology under the supervision of Prof. Robert M. Nerem. He was awarded his second scholarship while on sabbatical in June 2013 to carry out research in advanced materials for cardiac regeneration at Brigham and Women’s Hospital and Harvard Medical School in collaboration with Prof. Jeffrey Karp. Professor Duffy spent eight years in the Department of Anatomy, RCSI where he joined as a Lecturer in July 2008 and left as Associate Professor in 2016 to take up his current role at NUI Galway.
The Duffy Lab researchers have produced over 50 papers in leading journals, and submitted 21 invention disclosures leading to 6 patent applications and 1 granted patent.
+353 (0) 91 495833